Literature DB >> 29672399

Minimally Invasive Lobectomy Is Associated With Lower Noncancer-specific Mortality in Elderly Patients: A Propensity Score Matched Competing Risks Analysis.

Boris Hristov1, Takashi Eguchi1,2, Sarina Bains1, Joe Dycoco1, Kay See Tan3, James M Isbell1, Bernard J Park1, David R Jones1, Prasad S Adusumilli1,4.   

Abstract

OBJECTIVE: To investigate cancer- and noncancer-specific mortality following lobectomy by minimally invasive surgery (MIS) versus open thoracotomy in elderly patients with nonsmall cell lung cancer (NSCLC).
BACKGROUND: Two-thirds of patients with NSCLC are ≥65 years of age. As age increases, the risk of competing events, such as noncancer death, also increases.
METHODS: Elderly patients (≥65 yrs of age) who have undergone curative-intent lobectomy for stage I-III NSCLC without induction therapy (2002-2013) were included (n=1,303). Of those, 607 patients had undergone MIS and 696 had undergone thoracotomy. Propensity-score matching was performed to identify pairs of thoracotomy and MIS patients with comparable clinical characteristics (eg, year of surgery, comorbidities, and pulmonary function). Association between surgical approach (MIS vs thoracotomy) and lung cancer-specific and noncancer-specific cumulative incidence of death (CID) was analyzed using competing risks approach.
RESULTS: Following propensity score matching of patients who had undergone thoracotomy (n=338) versus MIS (n=338), MIS was associated with shorter length of stay (P <0.001), lower noncancer-specific 1-year mortality (P=0.027), and lower noncancer-specific CID (P=0.014) compared with thoracotomy; there was no difference in lung cancer-specific CID between surgical approaches. On multivariable analysis, thoracotomy was a significant risk factor for noncancer-specific death (subhazard ratio 2.45, 95% CI 1.18-5.06, P=0.016) independent of age, sex, and diffusion capacity of the lungs for carbon monoxide.
CONCLUSION: In a propensity score-matched cohort, multivariable analysis has indicated that lobectomy performed by MIS is associated with lower incidence of noncancer-specific mortality compared with lobectomy performed by open thoracotomy in elderly patients with NSCLC.

Entities:  

Mesh:

Year:  2019        PMID: 29672399     DOI: 10.1097/SLA.0000000000002772

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  4 in total

1.  Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.

Authors:  Yang Qu; Katsura Emoto; Takashi Eguchi; Rania G Aly; Hua Zheng; Jamie E Chaft; Kay See Tan; David R Jones; Mark G Kris; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-11-29       Impact factor: 15.609

2.  Oncologic validity of minimally invasive lobectomy for early stage lung cancer.

Authors:  Todd L Demmy; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 3.  Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer.

Authors:  Jamie E Chaft; Andreas Rimner; Walter Weder; Christopher G Azzoli; Mark G Kris; Tina Cascone
Journal:  Nat Rev Clin Oncol       Date:  2021-04-28       Impact factor: 65.011

4.  Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older.

Authors:  Hanbo Pan; Zenan Gu; Yu Tian; Long Jiang; Hongda Zhu; Junwei Ning; Jia Huang; Qingquan Luo
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.